Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Information sent to healthcare professionals in July 2009 about the safety of medicines

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

A list of letters sent to healthcare professionals in July 2009, to inform of new safety information and advice.

Date issued Product Safety information
July 29, 2009 Plavix (clopidogrel)PDF file (opens in new window) (73Kb) Potential interaction with proton pump inhibitors: clopidogrel may be less effective in patients also taking PPIs. See also Drug Safety Update July 2009, page 2 and clarification in Drug Safety Update September 2009, p 8.
See also letter to healthcare professionals sent 6 July 2009 about reporting of suspected adverse reactions to Tamiflu, Relenza and, when available, future swine flu H1N1 vaccines.

Page last modified: 07 September 2009